The Italian Pavilion at Expo 2025: a success beyond expectations The Osaka Expo has just ended, but the story of the Italian Pavilion continues. Among the 158 participating countries, Italy is the only one to continue its exhibition presence in Japan.

Italy and Japan in dialogue: art, science and the challenges of longevity At the Italian Embassy in Tokyo, a discussion between art and science as tools for improving quality of life, through two initiatives: the event Dialogue between Japan and Italy on Science, Culture and Longevity and the photographic exhibition Milan through the eyes of Leonardo da Vinci by the Bracco Foundation.

Bracco @ ECR 2026 Education is a pillar of innovation, and Bracco’s commitment. This effort has been comprised of cultivating and supporting radiology community through various continuing educational programs, mentorship opportunities, and strategic collaborations.

The European Commission granted Marketing Authorisation for Vueway® (gadopiclenol ) for its use in pediatric patients under 2 years Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces announces that on January 23, 2026, the European Commission (EC) granted the Marketing Authorisation for gadopiclenol in the European Union (EU) for pediatric patients below 2 years of age. 

The Sound of Innovation in Crete A new chapter of innovation unfolded on October 9, 2025, in Heraklion, Crete, during the Annual Meeting of the European Society of Medical Imaging Informatics (EuSoMII). In this context, the third edition of the EuSoMII/Bracco AI Contest took place—a unique, hands-on challenge designed to engage new generations of professionals in applying AI to real-world diagnostic problems.

Cell Therapy Target hard to isolate cell populations and subpopulations with our bead free, column free microbubble-based cell selection and activation technology. Our lipid based microbubbles provide a non-magnetic approach to cell selection and activation across cell therapy workflows.

The European Commission granted Marketing Authorisation for gadopiclenol for its use in pediatric patients under 2 years Bracco Imaging S.p.A., a global leader in diagnostic imaging, announces announces that on January 23, 2026, the European Commission (EC) granted the Marketing Authorisation for gadopiclenol in the European Union (EU) for pediatric patients below 2 years of age. 

Innovation in Cell Therapy: Bracco Imaging Forms Strategic Partnership with CellBri We’re proud to announce a new partnership between Bracco Imaging Medical Technologies (Shanghai) and Shenzhen Cellbri Bio-Innovation Technology, aimed at transforming CAR-T cell therapy manufacturing — one of the most promising areas in personalized cancer treatment.

Bracco and EuSoMII together at ECR – Hands on Challenge on Agentic AI Join us for an immersive, 2-hour hands-on challenge that brings the cutting edge of Agentic AI directly to the ECR floor. In this exclusive competition, 21 teams (2-3 participants each) will harness the power of mAIstro, a novel framework for orchestrating AI agents, to tackle complex workflows in brain tumor analysis.

Bracco Announces EU Launch of AiMIFY and Expands AI Portfolio At the 2026 European Congress of Radiology (ECR), Bracco Imaging S.p.A. today announced two major milestones in its AI & Digital Health strategy: the commercial launch in the European Union of AiMIFY® and a new strategic partnership with Avicenna.AI.